March 17, 2025

How Spaceflight Alters Human Physiology

From bone loss to vision impairment, spaceflight triggers changes in human physiology.

Reuters

March 06, 2025

An Estimated 31 Million Americans Borrowed for Medical Bills in 2024

A new West Health-Gallup Survey survey reveals insights into medical debt across all income levels and demographics in the United States.

Conexiant

February 26, 2025

Integration of Vision Services Remains an Unmet Need in FQHCs

Telemedicine, funding, and provider partnerships can help, researchers say.

Conexiant

June 10, 2024

Melatonin May Reduce Age-related Macular Degeneration Risk

Melatonin use is associated with a reduced risk of developing and progressing age-related macular degeneration.

Conexiant

July 03, 2024

Semaglutide Linked to Vision-Threatening Eye Disorder

New study finds that 8.9% of type 2 diabetes patients taking semaglutide experienced NAION, compared to 1.8% of those on non-GLP-1 diabetes drugs.

Reuters

December 16, 2024

Does Ozempic Double Eye Disease Risk?

Danish health authorities seek EU review of studies linking Novo Nordisk's Ozempic to rare eye condition in type 2 diabetes patients.

Reuters

November 08, 2024

Is Intravenous Methylprednisolone Efficacious for Visual Complications of GCA?

While timely treatment is essential to protect vision, the researchers found no visual acuity benefit with IVMP.

Conexiant

June 06, 2024

U.S. FDA Halts Biomea's Diabetes Trial

Biomea Fusion announced a clinical hold by the U.S. FDA on its diabetes drug trial due to potential toxic liver disease, causing a 60% drop in its shares.

Reuters

January 24, 2025

Once-Weekly Semaglutide Doubles Risk of NAION in T2D

“After the introduction of once-weekly semaglutide in Denmark in November 2018, the annual number of first-time NAION episodes reached an all-time high for the years 2019 through 2023.”

Conexiant